// App-Quantinova.ai

POS0321 (2021) : USE OF HYDROXYCHLOROQUINE AND SYSTEMIC SCLEROSIS: RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY ON THE EUSTAR COHORT

Researchers

Presenter

  • S. Bellando Randone

Principal Investigators

  • H. Wilhalme

  • C. Bruni

  • E. Siegert

  • P. Air

  • R. Irace

  • O. Distler

  • A. Doria

  • L. Czirjk

  • C. Denton

  • Y. Allanore

  • V. Riccieri

  • A. Vacca

  • I. Foeldvari

  • A. M. Hoffmann-Vold

  • A. Gabrielli

  • M. Matucci-Cerinic

  • D. Furst

Medical Centers

  • AOU Careggi, University of Florence, Hematology, Florence, Italy

  • University of California at Los Angeles, Department of Medicine, Division of Rheumatology, Los Angeles, United States of America

  • Charite University Hospital, Department of Rheumatology, Berlin, Germany

  • Spedali Civili di Brescia, Servizio di Reumatologia Allergologia e Immunologia Clinica, Brescia, Italy

  • II University of Naples, Division of Rheumatology, Naples, Italy

  • University Hospital Zurich, University of Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland

  • University of Padua, Rheumatology Unit, Dept. of Medicine - DIMED, Padua, Italy

  • VA Nasonova Research Institute of Rheumatology, Laboratory of Microcirculation and Inflammation, MOSCOW, Russian Federation

  • University of Pecs, Department of Rheumatology and Immunology, Pecs, Hungary

  • University College London Hospital, Department of Pathology, London, United Kingdom

  • Hopital Cochin Paris, Division of Rheumatology, Paris, France

  • ”La Sapienza” University, 11Department of Internal Medicine and Clinical Specialties, Rheumatology Unit, Rome, Italy

  • University of Cagliari-Policlinico Universitario, II Chair of Rheumatology, Monserrato, Italy

  • Hamburg Centre for Pediatric and Adolescence Rheumatology, Paediatric Rheumatology, Hamburg, Germany

  • Oslo University Hospital, Department of Pathology, Oslo, Norway

  • Università Politecnica delle Marche and Ospedali Riuniti, Department of Medical Science and Surgery, Section of Clinical Medicine, Ancona, Italy

Locations

  • Italy

  • United States

  • Germany

  • Switzerland

  • Russia

  • Hungary

  • United Kingdom

  • France

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A


Study Design

  • Observational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Boehringer Ingelheim

Result

  • N/A